MedPath

Characterization of Epileptic Motor Patterns by Tridimensional Analysis of Movement 2

Not Applicable
Terminated
Conditions
Epileptic Patients With Motor Manifestations During Seizures
Interventions
Device: 3-D accelerometric and magnetic sensors
Registration Number
NCT01025401
Lead Sponsor
University Hospital, Grenoble
Brief Summary

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

This is done to obtain a 3-D motor signature of seizures, for a given patient, and allows their detection with an ambulatory monitoring system.

The benefit for patients is to improve the diagnosis of their diseases by better characterizing their seizures.

Detailed Description

CAPAMETRIM 2 aims to characterize epileptic motor patterns by a quantitative three-dimensional analysis of movements.

The project is planned in three phases:

* Installation of 3-D accelerometric and magnetic sensors acquisition systems on the hospital (extension of a preceding study CAPAMETRIM).

* Collection of data on epileptic patients. Sensors will be positioned on the right and left hands and on the head. A 3-D analysis of movements will be done according to the collection by tagging data with visual analysis made on video.

* Development of a motor pattern classification system used for seizure detection.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adult or children (>= 6 years)
  • Written inform consented from the patient or its legal representative
  • Presurgical investigation of pharmaco-resistant partial epilepsy
  • Motor manifestations during seizures
Exclusion Criteria
  • Proved generalized epilepsy
  • No motor manifestations during seizures
  • Pregnant women
  • Subjects deprived of freedom by an administrative or judicial decision

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Motor manifestations during seizures3-D accelerometric and magnetic sensors-
Primary Outcome Measures
NameTimeMethod
3-D accelerometric and magnetic sensorscontinuously during hospitalization recordings (46 Hz from 9 h to 17 h)
Secondary Outcome Measures
NameTimeMethod
EEGcontinuously during hospitalization recordings (256-1024 Hz from 9 h to 17 h)
Videocontinuously during hospitalization recordings (25 fps from 9 h to 17 h)

Trial Locations

Locations (1)

Grenoble University Hospital Epilepsy Monitoring Unit

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath